Albion Financial Group Vertex Pharmaceuticals Inc Transaction History

Albion Financial Group

$1.61 Billion
Q3 2025

A detailed history of Albion Financial Group transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Albion Financial Group holds 1,109 shares of VRTX stock, worth $481,328. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,109

Previous 1,113 0.36%

Holding current value

$481,328

Previous $495,000 12.32%

% of portfolio

0.03%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 20, 2025	SELL	$366.54 - $479.53 $1,466 - $1,918	-4 Reduced 0.36%	1,109 $434,000
Q1 2025 Apr 25, 2025	SELL	$402.49 - $513.76 $91,365 - $116,623	-227 Reduced 16.94%	1,113 $539,000
Q4 2024 Jan 17, 2025	BUY	$396.64 - $516.74 $16,658 - $21,703	42 Added 3.24%	1,340 $539,000
Q3 2024 Oct 09, 2024	SELL	$460.0 - $505.78 $10,120 - $11,127	-22 Reduced 1.67%	1,298 $603,000
Q2 2024 Jul 10, 2024	SELL	$392.81 - $485.53 $29,460 - $36,414	-75 Reduced 5.38%	1,320 $618,000

Q1 2024 Apr 19, 2024	BUY	$407.69 - $446.08 $23,238 - $25,426	57 Added 4.26%	1,395 $583,000
Q4 2023 Jan 26, 2024	BUY	$343.0 - $410.68 $68,600 - $82,136	200 Added 17.57%	1,338 $544,000
Q3 2023 Nov 01, 2023	SELL	$338.18 - $362.46 $676 - $724	-2 Reduced 0.18%	1,138 $395,000
Q2 2023 Jul 25, 2023	SELL	$314.42 - $351.91 $70,115 - $78,475	-223 Reduced 16.36%	1,140 $401,000
Q1 2023 Apr 18, 2023	BUY	$283.23 - $323.1 $7,080 - $8,077	25 Added 1.87%	1,363 $429,000
Q4 2022 Feb 03, 2023	SELL	$285.76 - $321.48 $14,002 - $15,752	-49 Reduced 3.53%	1,338 $386,000
Q3 2022 Oct 27, 2022	BUY	$273.83 - $305.53 $10,953 - $12,221	40 Added 2.97%	1,387 $402,000
Q2 2022 Jul 29, 2022	SELL	$234.96 - $292.55 $123,119 - $153,296	-524 Reduced 28.01%	1,347 $380,000
Q1 2022 May 09, 2022	BUY	$221.42 - $260.97 $66,868 - $78,812	302 Added 19.25%	1,871 $488,000
Q4 2021 Feb 15, 2022	SELL	$177.01 - $223.45 $71,335 - $90,050	-403 Reduced 20.44%	1,569 $345,000
Q2 2021 Aug 12, 2021	SELL	$187.49 - $221.1 $937 - $1,105	-5 Reduced 0.25%	1,972 $398,000
Q4 2020 Feb 19, 2021	SELL	$207.01 - $276.09 $2,277 - $3,036	-11 Reduced 0.55%	1,977 $467,000
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $508,232 - $602,562	1,988 New	1,988 $541,000

Others Institutions Holding VRTX

# of Institutions

1,786

Shares Held

231M

Call Options Held

1.83M

Put Options Held

1.21M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $111B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Albion Financial Group , based on Form 13F filings with the SEC.

News

Stay updated on Albion Financial Group with notifications on news.

Account

Albion Financial Group Vertex Pharmaceuticals Inc Transaction History